Medaxes is pleased to announce that the Board of Directors has appointed Jasmien Coenen as the new Managing Director. She takes over the helm from Joris Van Assche who, to our great sadness, unexpectedly passed away on 8 August.
Until recently, Jasmien Coenen was CEO of Goed, a healthcare retailer active in Flanders with a network including some 80 pharmacies. Driven to lead large transformations, she led the merger of 14 companies. She has more than 10 years of experience in the healthcare sector and has held several management positions in the business world. Entrepreneurship with a 'purpose' is what drives her.
"The healthcare sector is in full swing. After the Corona crisis, which certainly brought opportunities to initiate long-awaited reforms, the momentum is there to anchor these reforms structurally and in the long term. The industry of generic and biosimilar medicines, of other off-patent medicines and self-care products has a very important role to play in this. I am excited to help steer this. From my professional past, I share the vision that accessible and affordable medicines have an important contribution to make to high quality healthcare. This is naturally reflected in the mission and objectives of Medaxes. It feels like a piece of the puzzle that fits nicely into my entire career”, concludes Jasmien Coenen.
Jef Hus, Chairman, confirms: "With her leadership, expertise and drive, Jasmien, together with her team and the Board of Directors, will further develop and carry out the mission and vision of Medaxes. In her enthusiasm and her focus on collaboration with various stakeholders, we found a real match in terms of vision and values. We give Jasmien all the support and confidence she needs to fulfil this challenge."
Jasmien Coenen will start as the new Managing Director of Medaxes on 1 October 2022.